The risk of using antiplatelet and/or anticoagulant treatment for hemorrhagic adverse events during EUS-guided biliary drainage
- PMID: 37208044
- DOI: 10.1016/j.gie.2022.12.023
The risk of using antiplatelet and/or anticoagulant treatment for hemorrhagic adverse events during EUS-guided biliary drainage
Comment on
-
Antiplatelet and/or anticoagulant treatment does not increase hemorrhagic adverse events during EUS-guided biliary drainage.Gastrointest Endosc. 2020 Sep;92(3):659-666. doi: 10.1016/j.gie.2020.04.038. Epub 2020 Apr 22. Gastrointest Endosc. 2020. PMID: 32334019
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
